Please sign in for the full experience | Flash sale 10% off | Addl. 10% off $750+ | Addl. 15% off $3000+

Peptide Research

Everything on this website – articles and product details – is meant for learning and information purposes only. The products we sell are designed for lab testing only (studies done in test tubes or petri dishes, not in living things). These products are not medications, treatments, or cures for any illness. They haven’t been reviewed or approved by the FDA.

  • May 1st

  • Peptidology Research Faculty

GHK-Cu Research Peptide: A Molecular Spark for Tissue Renewal

Origins & Discovery The tripeptide glycyl-L-histidyl-L-lysine (GHK) was isolated from human plasma in 1973 when Pickart observed that young serum “caused old liver tissue to produce proteins more characteristic of younger individuals.”​ Its high affinity for Cu²⁺ rapidly forms the chelate now known as GHK-Cu, which occurs naturally in plasma, saliva, and urine. Concentrations decline […]

  • April 30th

  • Peptidology Research Faculty

BPC-157 Research Peptide: Molecular Pathways and Healing Insights

Origins, Chemistry & Structural Biology BPC-157 (Body Protection Compound 157) is a 15-mer fragment (GEPPPGKPADDAGLV) originally isolated from human gastric juice and highly conserved across mammals. Its 1 414 Da mass and amphipathic profile confer remarkable aqueous stability—even in gastric acid—which in turn underpins wide laboratory utility. Structure–activity modelling reveals multiple proline clusters that resist […]

  • April 29th

  • Peptidology Research Faculty

CJC-1295/Ipamorelin Peptide: Synchronizing the Somatotropic Clock

CJC-1295/Ipamorelin is a research-grade blend that pairs a long-acting growth-hormone-releasing-hormone (GHRH) analogue, CJC-1295, with a selective growth-hormone secretagogue receptor (GHSR-1a) agonist, Ipamorelin. Individually, the two peptides engage complementary loci within the somatotropic axis—CJC-1295 mimics endogenous GHRH at the pituitary, while Ipamorelin allosterically activates the ghrelin receptor. Together, they have attracted attention as a tool for […]

  • April 4th

  • Peptidology Research Faculty

NA-931 Peptide: A Quadruple-Agonist Breakthrough in Obesity Research

Obesity is a complex metabolic condition affecting over 650 million adults worldwide, often accompanied by type 2 diabetes and other disorders. Traditional treatments, including diet, exercise, and even newer GLP-1 analog medications, have achieved significant weight loss but can come with limitations such as gastrointestinal side effects and unintended loss of lean muscle mass. This […]